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these blood donors frequently do not harbor HCV RNA 
and are not infectious. This is borne out by the absence 
of PTNANB hepatitis in the five recipients of anti- 
C100-3 HCV RNA-negative blood, whereas the only 
recipient of anti-C100-3-positive, HCV RNA-positive 
blood did contract PTNANB hepatitis. It would be of 
interest to know the subsequent clinical course of the 
donor of the latter blood. At present it is unclear whether 
HCV infection can occur without hepatitis, either 
acutely or chronically. If chronically infected, this donor 
could be analogous to a benign chronic carrier of HBsAg. 
Conversely, in view of Weiner’s data, one may question 
why this donor did not have hepatitis if viral replication 
and hepatitis appear to go hand in hand. Clearly there is 
much to be learned about the mechanisms of cellular 
injury in HCV infection. 
Garson’s study does not indicate whether there were 
any anti-HCV-negative cases of PTNANB hepatitis 
among the recipients of the 1,100 units of blood tested. 
In a previous study by Van der Poel et al. (61, of 5,150 
units of blood transfused into 383 recipients, 6 of 34 
(18%) recipients of anti-C100-3-positive blood con- 
tracted NANB hepatitis. This result is similar to that of 
Garson - one of six recipients of anti-C100-3-positive 
blood. Interestingly, in Van der Poel’s study, 3 of 349 
recipients of anti-C100-3-negative blood contracted 
NANB hepatitis. In contrast, Esteban et al. (7 )  have 
reported on 280 transfusion recipients of 1,109 units of 
blood among whom 27 (9.6%) contracted PTNANB 
hepatitis. In this study anti-HCV status was assessed by 
anti-C-100 ELISA and also by the more recently 
developed recombinant immunoblot assay, which recog- 
nizes antibodies to two HCV epitopes, C-100 and 5.1.1. 
HCV RNA was not measured. Sixteen of the 27 
PTNANB patients in Esteban’s study received anti- 
HCV-positive blood, whereas 11 received anti-HCV- 
negative blood. However, 24 of 27 patients with 
PTNANB hepatitis became anti-HCV-positive during 
52 wk of follow-up. Only two recipients of anti-HCV- 
positive blood did not contract PTNANB hepatitis. It 
is not clear why there was so marked a disparity in 
infectious potential of anti-HCV-positive blood between 
the studies by Garson and Van Der Poel and that of 
Esteban (18% vs. 88%). However, in agreement with 
Weiner’s data, one can infer from Esteban’s study that 
infectious HCV may be present in blood without de- 
tectable anti-HCV. The application of PCR technology to 
identification of HCV RNA in potentially infected sera 
is one possible solution to this clinical conundrum. 
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NEW INSIGHTS INTO CANALICULAR ORGANIC 
ANION SECRETION 
Oude Elferink RPJ, Ottenhoff R, Liefting WGM, Schoe- 
maker B, Groen AK,  Jansen PLM. ATP-dependent efflux 
of GSSG and GS-conjugate from isolated rat hepato- 
cytes. Am J Physiol 1990;258:G699-G706. 
EDITOR’S ABSTRACT 
The effect of partial and complete dissipation of the 
membrane potential and partial depletion of cellular 
ATP content on the efflux of dinitrophenyl-glutathione 
and oxidized glutathione was examined in hepatocytes 
isolated from normal and mutant (TR- ) rats exhibiting 
defective organic anion transport. Whereas alterations 
in the membrane potential difference had no effect on 
the initial efflux rate of dinitrophenyl-glutathione and 
oxidized glutathione, depletion of cellular ATP in- 
hibited dinitrophenyl-glutathione and oxidized glu- 
tathione efflux and a linear relationship between the 
cellular ATP content and the initial efflux rate of 
dinitrophenyl-glutathione was observed in normal iso- 
lated rat hepatocytes. In contrast, depletion of cellular 
ATP content had no significant effect on the slower rate 
of dinitrophenyl-glutathione efflux from TR- rat he- 
patocytes. These findings implicate an ATP-dependent 
hepatic transport system for oxidized glutathione and 
glutathione conjugates that is absent in TR- mutants. 
Kitamura T,  Jansen P, Hardenbrook, Kamimoto Y, 
Gatmaitan 2, Arias IM. Defective ATP-dependent bile 
canalicular transport of organic anions in mutant (TR 1 
rats with conjugated hyperbilirubinemia. Proc Natl 
Acad Sci USA 1990;87:3557-3561. 
EDITOR’S ABSTRACT 
Fluorescence image analysis reveals normal se- 
cretion of a fluorescent bile acid (fluorescein isothiocy- 
anate glycocholate into the canalicular lumen of iso- 
lated normal and TR- mutant rat hepatocyte couplets, 
but negligible canalicular accumulation of a non-bile- 
acid organic anion (carboxydichlorofluorescein diac- 
etate) in TR- hepatocyte couplets. Canalicular mem- 
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brane vesicles derived from normal rats exhibited 
saturable temperature- and ATP-dependent transport 
of sulfobromophthalein and sulfobromophthalein- 
glutathione that was absent in canalicular membrane 
vesicles from TR- rats. However, ATP-dependent 
daunomycin transport, reflecting transport medi- 
ated by the multidrug resistance gene product, p- 
glycoprotein, was present in canalicular membrane 
vesicles from both normal and TR- rats. Canalicular 
membrane vesicles from normal and TR- rats con- 
tained equal amounts of p-glycoprotein on immuno- 
blots. These studies demonstrate that the conjugated 
hyperbilirubinemia in TR- mutant rats is the result of 
a functional absence of an ATP-dependent organic 
anion transport system on the canalicular membrane. 
COMMENTS 
The biliary excretion of organic anions, derived from 
either endogenous metabolism or xenobiotics, repre- 
sents one of the major functions of the liver. Inborn 
errors of metabolism demonstrate that separate cana- 
licular membrane transport processes exist for the 
excretion of these organic anions. Thus in Dubin- 
Johnson syndrome and in mutant Corriedale sheep, 
biliary excretion of conjugated bilirubin is defective, 
whereas bile acid secretion is intact. Yet, in comparison 
with our understanding of the mechanisms of cana- 
licular bile acid transport, little was known about the 
driving forces of canalicular secretion of other organic 
anions such as bilirubin and glutathione. Recently a 
mutant rat strain ( T R - )  was discovered that has 
autosomal, recessive, conjugated hyperbilirubinemia ( 1) 
and defective biliary excretion of conjugated bilirubin, 
bromosulphthalein (BSP), dibromosulfphthalein and 
ouabain but normal biliary excretion of taurocholate, 
cholate and a quaternary organic cation (1, 2). In 
addition, glutathione and glutathione conjugates were 
not transported into the bile of the TR- rat (3). Because 
of the information from these descriptive studies, these 
two reports now characterize the nature of this selective 
defect in organic anion excretion at the membrane level. 
The findings clearly represent an important advance in 
our understanding of the hepatic handling of non-bile- 
acid organic anions. 
In the first report, hepatocytes were loaded with 
S-dinitrophenyl glutathione (DNP-SG) by incubation in 
l-chloro-2,4-dinitrobenzene, a compound rapidly taken 
up by the cells and conjugated to glutathione. As 
previously reported (3), DNP-SG efflux from T R -  
hepatocytes was markedly slower than that from normal 
hepatocytes. Depolarization of the plasma membrane 
potential, estimated by the intracellular and extracel- 
lular equilibrium distribution of chloride by several 
means, including replacement of K' for Na' and 
inhibition of Na + , K + -ATPase activity, had little effect 
on DNP-SG efflux from normal hepatocytes. Next, the 
effect of depletion of cytosolic ATP on DNP-SG efflux 
was examined under various experimental conditions. 
Incubation of cells with fructose or glycerol or glycerol 
with ethanol has been reported to result in rapid 
intracellular phosphorylation of these substrates at the 
expense of cytosolic ATP. Incubation with atractyloside, 
antimycin A and valinomycin have all been shown to 
inhibit separate steps in the production and mainte- 
nance of cytosolic ATP. Each condition resulted in 
significant inhibition of DNP-SG efflux from normal 
hepatocytes, with a linear correlation established be- 
tween ATP depletion by atractyloside and DNP-SG 
efflux. No significant inhibition of DNP-SG efflux was 
observed in TR- hepatocytes after depletion of cellular 
ATP with fructose incubation or with atractyloside. In 
similar experiments, the ATP dependence of oxidized 
glutathione (GSSG) efflux in normal hepatocytes was 
established. 
Both the plasma membrane potential and cellular ATP 
content have been shown previously to play a role in 
the secretion of reduced glutathione (GSH) in isolated 
hepatocytes (4). The apparent discrepancy between 
these and the above findings can be resolved if one 
accepts that GSH efflux is a predominantly sinusoidal 
event, whereas-GSSG and DNP-GS efflux occurs in the 
canalicular membrane domain. Furthermore, it should 
be noted that there is even a lack of consensus on the role 
of the membrane potential in sinusoidal GSH efflux ( 5 ) .  
The inherent difficulty in establishing the membrane 
localization for this and any transport process using 
isolated hepatocytes as an experimental model is 
overcome in the second study. Using isolated hepatocyte 
couplets that retain a canalicular lumen, Kitamura 
et al. demonstrate by conventional and confocal fluo- 
rescence microscopy normal fluorescein isothiocyanate 
glycocholate secretion but no carbodichlorofluorescein 
diacetate secretion into the canalicular space in TR- 
hepatocyte couplets, despite similar cytoplasmic accu- 
mulation relative to normal hepatocyte couplets. Then, 
using isolated canalicular membrane vesicles (CMV) free 
of basolateral membrane contamination as assessed 
by absent Na' , K + -ATPase activity, ATP-dependent 
transport of BSP and BSP-GSH present in normal CMV 
was shown to be absent in TR- ChW. The presence of 
ATP-dependent daunomycin transport in TR- CMV 
both functionally and immunologically points further to 
the selective nature of the transport defect in TR- CMV. 
Previous work in a canalicular CMV vesicle model had 
suggested that transport of GSSG (6) and glutathione 
S-conjugates using DNP-SG as a model compound (7) 
was an electrogenic carrier-mediated process. More 
recently, however, ATP-dependent transport of DNP-SG 
was demonstrated in the liver, although the membrane 
localization of this transport system was uncertain 
(8, 9). Similar ATP-dependent transport systems for 
glutathione S-conjugates have been described in the 
heart and in erythrocytes (20, 11). 
Like all important work, these studies raise additional 
questions. Is GSH efflux at the sinusoidal membrane an 
ATP-dependent process as well and, if so, is the defect in 
TR- rats and in Dubin-Johnson syndrome the result of 
defective sorting from the basolateral to the canalicular 
membrane of a functional transport protein or normal 
sorting of a functionally defective transport protein to 
the canalicular membrane? The finding that BSP and 
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BSP-GSH binding to TR- CMV was similar to that 
observed in normal CMV would suggest the latter 
hypothesis. 
Clearly the combined effect of the findings from these 
two studies is more than just a better description of 
canalicular non-bile-acid organic anion secretion. Be- 
cause the transport defect has been characterized in a 
mutant animal model, it is only a matter of time before 
the membrane protein involved in the canalicular 
secretion of non-bile-acid organic anions will be iden- 
tified. Radioactive photoaffinity labels are available for 
the detection of glutathione S-conjugate-binding mem- 
brane proteins (12). Once isolated, further studies 
including molecular cloning of this protein will follow. 
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OMEPRAZOLE AND ARYL HYDROCARBON 
HYDROXYLASES: SHOULD WE BE WORRIED? 
Diaz D, Fabre I ,  D a j a t  M, Saint Aubert B, Bories P, 
Michel H, Maurel P. Omeprazole is an aryl 
hydrocarbon-like inducer of human hepatic cytochrome 
P450. Gastroenterology 1990;99:737-747. 
EDITOR’S ABSTRACT 
Diaz and colleagues have carefully studied the ef- 
fects of omeprazole on the expression of cytochrome 
P-450 in primary cultures of human hepatocytes. When 
omeprazole was added to the culture medium in 
varying concentrations, there was an increase in P- 
450IA2 protein and mRNA concentrations, an increase 
in de novo synthesis of P-45OIA2 protein, and an 
increase in microsomal catalytic activities character- 
istic of P-45OIA2 (phenacetin deethylase and acet- 
anilide hydroxylase). Omeprazole treatment also re- 
sulted in an increase in both enzymatic activity char- 
acteristic of P-45OIA1 (ethoxyresorufin deethylase and 
benzpyrene hydroxylase) and concentration of P- 
450IAl mRNA. In contrast, omeprazole appeared to 
have no significant effect on expression of other P-450s 
within the P-45011 or P-450111 families in the hepato- 
cytes. To validate these in uitro observations, liver 
biopsy specimens were obtained from five patients 
before and after a 4-day course of pharmacological 
doses of omeprazole. In each patient, omeprazole 
treatment appeared to result in a two- to eightfold 
increase in P-45OIA2 immunoreactive protein and 
P-45OIA1 and P-45OIA2 enzymatic activities. 
The authors conclude that omeprazole is an inducer 
of P-45OIA2 and probably P-450IA1 in human liver. 
Induction of these enzymes could potentiate the bio- 
activation of carcinogens or the hepatotoxicity of some 
drugs such as acetaminophen. 
COMMENTS 
This is an important article likely to spark consid- 
erable controversy. The data presented and the accom- 
panying editorial (1) appear to raise new concerns about 
the safety of omeprazole (Losec; Merck, Sharp & Dohme, 
Division ofMerck 8z Co., Inc., West Point, PA). This drug 
is the latest addition to the peptic ulcer disease thera- 
peutic arsenal, which accounts for sales well in excess of 
$1 billion annually. As the most potent inhibitor of 
gastric acid secretion clinically available, omeprazole is 
already used widely in the treatment of severe esoph- 
agitis, Zollinger-Ellison syndrome and refractory peptic 
ulcer disease. 
Diaz et al. investigated the effects of omeprazole on 
the regulation of phase I drug metabolizing enzymes 
termed cytochromes P-450 (P-450s). P-450s often play 
critical roles in the metabolism of drugs and other 
xenobiotics found in the environment (2, 3). The P-450 
literature has recently been simplified by the adoption of 
nomenclature that classifies individual P-450 enzymes 
by gene family (designated by roman numerals) (4). 
Three major P-450 families appear to be involved in 
xenobiotic metabolism, each consisting of proteins that 
share >40% amino acid sequence homology. Each 
family contains subfamilies of proteins (designated by 
capital letters) that share >60% amino acid sequence 
homology. This nomenclature replaces other classifi- 
cations that often designated P-450s by substrate 
specificity or by response to known inducers. The 
enzymes demonstrated to be induced in the hepatocytes 
by Dim et al. (P-45OIA1 and P-450IA2) are “aryl 
hydrocarbon hydroxylases” and correspond to what has 
also been termed “P-448.” 
